<DOC>
	<DOCNO>NCT00403338</DOCNO>
	<brief_summary>1500 eligible patient treat commercially available CYPHER® sirolimus-eluting Bx Velocity™ stent . Patients follow twelve month post-procedure , watch patient require repeat procedure diseased area coronary artery .</brief_summary>
	<brief_title>The Impact Stent Deployment Techniques Clinical Outcomes Patient Treated With CYPHER® Stent ( S.T.L.L.R . )</brief_title>
	<detailed_description>Geographical miss associate treatment failure intracoronary radiation therapy . This phenomenon , secondary vascular injury outside treat segment , strongly correlate development restenosis edge treat coronary segment . The European Canadian SIRIUS trial ( E C-SIRIUS ) randomize 350 patient similar baseline characteristic US SIRIUS study . Operators use short post-dilatation balloon direct stented 27 % patient , achieve 4.0 % TLR rate 5.1 % in-lesion binary restenosis . These somewhat superior result support concept refinement deployment technique may improve clinical outcome drug-eluting stent .</detailed_description>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Inclusion criterion : Diagnosis de novo stenosis major coronary artery Can treat stent Candidate bypass Exclusion criterion : Recent , severe MI Prior brachytherapy Impaired leave ventricle function Heart transplant recipient Impaired renal function Disease vein graft previous bypass Similar treatment within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>myocardial ischemia</keyword>
	<keyword>coronary disease</keyword>
	<keyword>heart disease</keyword>
	<keyword>Coronary Stenosis [ MeSH heading : C14.280.647.250.285 ]</keyword>
</DOC>